RECRUITING

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study has 3 aims. Aim 1: Identify social determinants of cardiometabolic health and determine facilitators and modifiable barriers in achieving treatment goals. Aim 2: Assess PLWH knowledge, skills, and confidence for self-management of cardiometabolic disorders. Aim 3: Tailor a self-management support and education intervention with stakeholder input to address barriers to achieving treatment goals for cardiometabolic disorders in PLWH at the study sites.

Official Title

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for Persons Living With HIV in the Southeastern United States

Quick Facts

Study Start:2022-06-07
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05129345

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes.
  2. * Participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. Age 18 or older.
  1. * Those who don't understand English and those who are blind.

Contacts and Locations

Study Contact

Stuart T Carr, BA
CONTACT
919 668-4849
stuart.carr@duke.edu
Charles Muiruri, PhD
CONTACT
919 660-3212
charles.muiruri@duke.edu

Principal Investigator

Charles Muiruri, PhD
PRINCIPAL_INVESTIGATOR
Duke University

Study Locations (Sites)

Duke University - Charlotte Study Sites
Charlotte, North Carolina, 28205
United States
Duke University - Duke Study Site
Durham, North Carolina, 27710
United States

Collaborators and Investigators

Sponsor: Duke University

  • Charles Muiruri, PhD, PRINCIPAL_INVESTIGATOR, Duke University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-07
Study Completion Date2025-06

Study Record Updates

Study Start Date2022-06-07
Study Completion Date2025-06

Terms related to this study

Keywords Provided by Researchers

  • Hypertension
  • Dyslipidemias
  • Type 2 Diabetes
  • HIV-1-infection

Additional Relevant MeSH Terms

  • Hypertension
  • Dyslipidemias
  • Type 2 Diabetes
  • HIV-1-infection